Close
ACHEMA MIDDLE EAST 2026

Merck Announces Acquisition of Cidara Therapeutics at $9.2 B

Merck announced that it will acquire Cidara Therapeutics, Inc., after both companies confirmed they have signed a definitive agreement. The deal, executed through a...

Novartis Opens Radioligand Therapy Manufacturing Plant in US

Novartis, a leader in innovative medicines, has launched a 10,000-square-foot radioligand therapy (RLT) manufacturing facility in Carlsbad, California. The site marks an important step...

Building the Right Team and Resource Model to Support Quality System and Validation Activities

Since life science quality and validation projects can vary widely in scope and complexity, each specific project needs to be evaluated in order to...

Lilly to Expand its Manufacturing Facility in Puerto Rico

Eli Lilly and Company has unveiled plans to invest more than $1.2 billion to expand and modernize its Lilly del Caribe manufacturing site in...

Lilly to Build $3B Manufacturing Facility in Netherlands

Eli Lilly and Company is investing $3 billion to build a new manufacturing facility in Katwijk, the Netherlands, within the Leiden Bio Science Park....

FDA Unveils Initiative for Faster Biosimilar Development

The U.S. Food and Drug Administration (FDA) has unveiled a major initiative aimed at cutting both the time and cost required to develop biosimilar...

Novartis to Acquire Avidity Biosciences in $12 Billion Deal

Swiss pharmaceutical company Novartis announced that it has reached an agreement to acquire U.S.-based biotechnology firm Avidity Biosciences in a cash deal valued at...

Subscribe Our Newsletter

White Papers

The Future of Digital Health

The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....

Five Best Practices to Deliver Exceptional Multichannel Experiences

A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...

The Impact and Use of Social Media in Pharmacovigilance

Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...